Work

Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies

Year: 2008

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-008-9135-2

Authors: Priscila H. Goncalves, Francine High, Paul Juniewicz, Gareth Shackleton, Jing Li, Scott Boerner, Patricia M. LoRusso

Institutions: Wayne State University, The Barbara Ann Karmanos Cancer Institute, Sanofi (France), Sanofi (United Kingdom)

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: CANCER CENTER SUPPORT GRANT

OpenAlex ID: W2047966454

FWCI: 0.496

Cites: 23

Cited by: 11

Related to: 10